StemRIM Inc.
Develops regenerative medicine that uses the body's own stem cells for tissue repair.
4599 | T
Overview
Corporate Details
- ISIN(s):
- JP3399690001
- LEI:
- Country:
- Japan
- Address:
- 茨木市彩都あさぎ７丁目７番１５号
- Website:
- https://stemrim.com/english/
Description
StemRIM Inc. is a biotechnology company developing a next-generation category of regenerative medicine called “Regeneration-Inducing Medicine™”. This innovative approach aims to treat intractable diseases and injuries by maximizing the body's innate tissue repair capabilities. The core mechanism of action involves mobilizing a patient's own endogenous stem cells to damaged tissues to induce functional regeneration, a method distinct from conventional cell-therapy. The company's research and development focuses on creating new drugs based on this novel mechanism, with applications including gene therapy for rare skin diseases such as dystrophic epidermolysis bullosa.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-12-13 04:00 |
四半期報告書－第15期第1四半期(2019/08/01－2019/10/31)
|
Japanese | 141.9 KB | ||
| 2019-10-29 01:45 |
訂正有価証券報告書－第14期(平成30年8月1日－令和1年7月31日)
|
Japanese | 1.2 MB | ||
| 2019-10-25 02:31 |
有価証券報告書－第14期(平成30年8月1日－令和1年7月31日)
|
Japanese | 2.5 MB |
Automate Your Workflow. Get a real-time feed of all StemRIM Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for StemRIM Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for StemRIM Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
